GLICK GARY D enters ODYSSEY THERAPEUTICS, INC. with 388.59K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 388.59K | Direct |
| Total | 388.59K | 388.59K direct |
Stock Option (Right to Buy)
DirectUnderlying shares
13.38K
Shares owned
N/A
Exercise price
3.98
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
128.77K
Shares owned
N/A
Exercise price
3.98
Expiration
—
Exercise window
—
Series C Convertible Preferred Stock
DirectUnderlying shares
10.29K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
941.43K
Shares owned
N/A
Exercise price
4.18
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
372.35K
Shares owned
N/A
Exercise price
3.98
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
313.81K
Shares owned
N/A
Exercise price
4.18
Expiration
—
Exercise window
—
Series D Convertible Preferred Stock
DirectUnderlying shares
17.09K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
1.80M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 3.98 | — | — | 13.38K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.98 | — | — | 128.77K | N/A |
| Series C Convertible Preferred Stock Direct | Common Stock | — | — | 10.29K | N/A | |
| Stock Option (Right to Buy) Direct | Common Stock | 4.18 | — | — | 941.43K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.98 | — | — | 372.35K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 4.18 | — | — | 313.81K | N/A |
| Series D Convertible Preferred Stock Direct | Common Stock | — | — | 17.09K | N/A | |
| Total | 1.80M | 0.00 | ||||